Compare AbCellera Biologics Inc (ABCL) vs iShares Core S&P 500 ETF (IVV) Price & Performance

AbCellera Biologics IncTrade

iShares Core S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs iShares Core S&P 500 ETF — how do they compare? AbCellera Biologics Inc trades at $9.26 (market cap $2.99B), while iShares Core S&P 500 ETF trades at $777.14. Which is the better fit depends on your goals.

	ABCL	IVV
Market Cap	$2.99B	—
Sector	Health	Broad Market / Factor
52-Week High	$9.76	$776.81
52-Week Low	$2.78	$634.93
Enterprise Value	$2.58B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABCL

View details →

IVV

WisdomTree U.S. Total Dividend ETF (DTD) rated 'hold' for balanced factors but overlaps 57% with S&P 500 ETFs.Seeking Alpha · 1 day agoNeutral Main Sector Rotation ETF (SECT) gets Hold rating due to weak performance versus IVV.Seeking Alpha · 4 days agoNeutral View details →

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.